NSABP B-39 RTOG 0413

Complete

Return to Protocol Table

A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

Principal Investigator

Frank Vicini, MD

Status

Complete

Date Opened To Accrual

March 21 2005

Date Closed to Accrual

April 16 2013

Date of Study Termination

January 31 2019

Disease Site

Breast [BR]

Breast

Phase

III

Developmental Therapeutics

Primary Objective

To determine whether partial breast irradiation (PBI) limited to the region of the tumor bed following lumpectomy provides equivalent local tumor control in the breast compared to conventional whole breast irradiation (WBI) in the local management of early stage breast cancer.

Patient Population

Patients with Stage 0, I, or II Breast Cancer Resected by Lumpectomy; Tumor Size ≤ 3.0 cm; No More Than 3 Histologically Positive Nodes

Target Accrual

4214

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.

Study Memos

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.